Ledger. Australian venture funding, tracked

Company

MRCF

Coverage

Stories naming MRCF. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

3 deals

Australian pain drug innovation company Spinifex Pharmaceuticals sold to Novartis for US$200m plus milestone payments

GBS Ventures reports Novartis has agreed to acquire chronic-pain drug developer Spinifex Pharmaceuticals for US$200 million upfront plus milestones, recalling the company's 2005, 2008 and 2014 venture rounds and its Australian investors.

GBS Ventures 30 Jun 2015 Spinifex PharmaceuticalsBourns Semiconductor IncBrandon CapitalBT ImagingFibrotechFultecHatchtechHydrexiaMRCFNovartisNovo A/SQuest Software Inc.Shire plcSmart SparrowVintelaAustralianSuperCanaan PartnersGBS VenturesMTAA SuperNovo VenturesThe University of QueenslandUniQuestUniseedUniversity of MelbourneUniversity of New South WalesDr Andrew BakerBrigitte SmithDr Bruce WyseDr Chris NaveProf Maree SmithMark AshtonDr Peter DevineDr Tom McCarthy

Also GBS Ventures·novartis.com·clinicalleader.com·Startup Daily·Startup Daily·anthillonline.com·@AuManufacturing·materresearch.org.au·Business News Australia

Something wrong? Tell us